1887

Abstract

The use of antimicrobial agents in the management of patients infected with Shiga toxin-producing (STEC) O157 : H7 remains controversial. Here, we examined the antibacterial efficacy of a natural product, ellagitannin from (Qi 4), against the organism in a murine model. Streptomycin-pretreated mice were orogastrically inoculated with 2×10 c.f.u. streptomycin-resistant O157 : H7. The results demonstrated a stable high level of STEC present in the faeces of the infected animals. The bacterial levels in infected mice receiving Qi 4 at MIC and 2×MIC were not significantly different from those of the untreated group (-test; >0.05). In contrast, Qi 4 at 4×MIC significantly reduced the numbers of STEC within 2 days (-test; 0.05>>0.01). No viable bacteria were detected between day 5 and day 10. Similarly, at day 10, no organisms were detected from the intestines of the Qi 4-treated group, while they were recovered at levels of 10 and 10 c.f.u. g in the colons and caeca of the infected mice, respectively. Histopathological findings from the infected kidneys revealed a marked increase in the number of mesangial cells and mesangial matrix. Ultrastructural examination of the kidneys from the infected mice also demonstrated proliferation of mesangial cells and an increase in the mesangial matrix. Cellular injury of endothelial cells with irregular borders and cytoplasmic bleb formation were noted. In contrast, the effects were not observed in the animals treated with Qi 4. The results clearly indicated that administration of Qi 4 could effectively eradicate the colonization of STEC O157 : H7 in the intestinal tract of mice and prevent renal injury. This compound may be an alternative candidate for a therapeutic agent against infections caused by this dangerous organism.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.044495-0
2012-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/10/1366.html?itemId=/content/journal/jmm/10.1099/jmm.0.044495-0&mimeType=html&fmt=ahah

References

  1. Babiuk S., Asper D. J., Rogan D., Mutwiri G. K., Potter A. A. 2008; Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157 : H7 in mice. Microb Pathog 45:7–11 [View Article][PubMed]
    [Google Scholar]
  2. Basri D. F., Fan S. H. 2005; The potential of aqueous and acetone extracts of galls of Quercus infectoria as antibacterial agents. Indian J Pharmacol 37:26–29 [View Article]
    [Google Scholar]
  3. Chusri S., Voravuthikunchai S. P. 2009; Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections. J Appl Microbiol 106:89–96 [View Article][PubMed]
    [Google Scholar]
  4. Fincher L. M., Parker C. D., Chauret C. P. 2009; Occurrence and antibiotic resistance of Escherichia coli O157 : H7 in a watershed in north-central Indiana. J Environ Qual 38:997–1004 [View Article][PubMed]
    [Google Scholar]
  5. Funatogawa K., Ide T., Kirikae F., Saruta K., Nakano M., Kirikae T. 2002; Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157 : H7 in mice. Microbiol Immunol 46:761–766[PubMed] [CrossRef]
    [Google Scholar]
  6. Gagnon M., Kheadr E. E., Dabour N., Richard D., Fliss I. 2006; Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157 : H7 infection in BALB/c mice. Int J Food Microbiol 111:26–33 [View Article][PubMed]
    [Google Scholar]
  7. Isogai E., Isogai H., Takeshi K., Nishikawa T. 1998; Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157 : H7 strain. Microbiol Immunol 42:125–128[PubMed] [CrossRef]
    [Google Scholar]
  8. Kaur G., Athar M., Alam M. S. 2008; Quercus infectoria galls possess antioxidant activity and abrogates oxidative stress-induced functional alterations in murine macrophages. Chem Biol Interact 171:272–282 [View Article][PubMed]
    [Google Scholar]
  9. LeBlanc J. J. 2003; Implication of virulence factors in Escherichia coli O157 : H7 pathogenesis. Crit Rev Microbiol 29:277–296 [CrossRef]
    [Google Scholar]
  10. McCutcheon A. R., Ellis S. M., Hancock R. E. W., Towers G. H. N. 1992; Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol 37:213–223 [View Article][PubMed]
    [Google Scholar]
  11. Mølbak K., Mead P. S., Griffin P. M. 2002; Antimicrobial therapy in patients with Escherichia coli O157 : H7 infection. JAMA 288:1014–1016 [View Article][PubMed]
    [Google Scholar]
  12. O’Brien A. D., Kaper J. B. 1998; Shiga toxin-producing Escherichia coli: yesterday, today, and tomorrow. In Escherichia coli O157 : H7 and Other Shiga Toxin-Producing E. coli Strains pp. 1–11 Edited by Kaper J. B., O’Brien A. D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  13. Obrig T. G., Del Vecchio P. J., Brown J. E., Moran T. P., Rowland B. M., Judge T. K., Rothman S. W. 1988; Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373–2378[PubMed]
    [Google Scholar]
  14. Richardson S. E., Karmali M. A., Becker L. E., Smith C. R. 1988; The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19:1102–1108 [View Article][PubMed]
    [Google Scholar]
  15. Robinson C. M., Sinclair J. F., Smith M. J., O’Brien A. D. 2006; Shiga toxin of enterohemorrhagic Escherichia coli type O157 : H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 103:9667–9672 [View Article][PubMed]
    [Google Scholar]
  16. Sugita-Konishi Y., Hara-Kudo Y., Amano F., Okubo T., Aoi N., Iwaki M., Kumagai S. 1999; Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157 : H7. Biochim Biophys Acta 1472:42–50 [View Article][PubMed]
    [Google Scholar]
  17. Suwalak S., Voravuthikunchai S. P. 2009; Morphological and ultrastructural changes in the cell structure of enterohaemorrhagic Escherichia coli O157 : H7 following treatment with Quercus infectoria nut galls. J Electron Microsc (Tokyo) 58:315–320 [View Article][PubMed]
    [Google Scholar]
  18. Vattem D. A., Lin Y.-T., Labbe R. G., Shetty K. 2004; Phenolic antioxidant mobilization in cranberry pomace by solid-state bioprocessing using food grade fungus Lentinus edodes and effect on antimicrobial activity against select food borne pathogens. Innov Food Sci Emerg Technol 5:81–91 [View Article]
    [Google Scholar]
  19. Voravuthikunchai S. P., Limsuwan S. 2006; Medicinal plant extracts as anti-Escherichia coli O157 : H7 agents and their effects on bacterial cell aggregation. J Food Prot 69:2336–2341[PubMed]
    [Google Scholar]
  20. Voravuthikunchai S. P., Suwalak S. 2008; Antibacterial activities of semipurified fractions of Quercus infectoria against enterohemorrhagic Escherichia coli O157 : H7 and its verocytotoxin production. J Food Prot 71:1223–1227[PubMed]
    [Google Scholar]
  21. Voravuthikunchai S. P., Limsuwan S., Chusri S. 2007; New perspectives on herbal medicines for bacterial infections. In Recent Progress in Medicinal Plants vol. 18 Natural Products II pp. 41–101 Edited by Govil G. N., Singh V. K., Siddqui T. Houston: Studium Press LLC;
    [Google Scholar]
  22. Voravuthikunchai S. P., Chusri S., Suwalak S. 2008; Quercus infectoria Oliv. Pharm Biol 46:367–372 [View Article]
    [Google Scholar]
  23. Wiart C., Kumar A. 2001 A Practical Handbook of Pharmacognosy Petaling Jaya: Pearson Education, Malaysia Sdn Bhd;
    [Google Scholar]
  24. Wilkerson C., Samadpour M., van Kirk N., Roberts M. C. 2004; Antibiotic resistance and distribution of tetracycline resistance genes in Escherichia coli O157 : H7 isolates from humans and bovines. Antimicrob Agents Chemother 48:1066–1067 [View Article][PubMed]
    [Google Scholar]
  25. Wu V. C. H., Qiu X., de los Reyes B. G., Lin C.-S., Pan Y. 2009; Application of cranberry concentrate (Vaccinium macrocarpon) to control Escherichia coli O157 : H7 in ground beef and its antimicrobial mechanism related to the downregulated slp, hdeA and cfa . Food Microbiol 26:32–38 [View Article][PubMed]
    [Google Scholar]
  26. Yoh M., Frimpong E. K., Honda T. 1997; Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157 : H7. FEMS Immunol Med Microbiol 19:57–64 [View Article][PubMed]
    [Google Scholar]
  27. Yoh M., Frimpong E. K., Voravuthikunchai S. P., Honda T. 1999; Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157 : H7. Can J Microbiol 45:732–739[PubMed] [CrossRef]
    [Google Scholar]
  28. Zoja C., Remuzzi G. 1992; The pivotal role of the endothelial cell in the pathogenesis of HUS. In Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura pp. 389–404 Edited by Kaplan B. S., Trompeter R. S., Moake J. L. New York: Marcel Dekker;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.044495-0
Loading
/content/journal/jmm/10.1099/jmm.0.044495-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error